Related Experiment Videos
Germ cell tumors
D F Bajorin1, R J Motzer, G J Bosl
1Cornell University Medical College, New York, New York.
Current Therapy in Endocrinology and Metabolism
|January 1, 1994
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author
Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma.
ESMO open·2025
Same author
Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: a modeling analysis based on the CheckMate 9ER study.
ESMO open·2025
Same journal
Growth hormone deficiency in the elderly.
Current therapy in endocrinology and metabolism·1997
Same journal
Sexual function in menopause and postmenopause.
Current therapy in endocrinology and metabolism·1997